EUVIMEDEUVIMED entdecken
Crossref

Identification of Mitapivat's In Vivo Metabolites in the Rat Model by Quadrupole‐Time‐of‐Flight (Q‐TOF) Mass Spectrometry

Saurabh Pandurang Bodake, Anjali Mukesh, Akshay Bandgar, Kannan Shajkumar, Shrutika Wankhade, Anandhu Kunnath Shaji, Swapnil Jayant Dengale iD

Journal of Mass Spectrometry · 2025

DOI: 10.1002/jms.5126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Mass Spectrometry, 2025. Verfasst von Saurabh Pandurang Bodake und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, India. Hauptthemen laut MEDLINE: Pyridines. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitapivat is a novel, first‐in‐class, allosteric activator of pyruvate kinase enzyme. It has been approved by the US FDA in February 2022 for disease modifying treatment of haemolytic anaemia in adults. In the current study, the in vivo metabolites of mitapivat in the rat model were identified using quadrupole‐time‐of‐flight mass spectrometry. A total 20 metabolites were identified, out of which nine metabolites were found to be novel and reported first time in the literature. The study also further refined the chemical structures of some of the reported metabolites. Oxidation, N‐dealkylation, oxidation followed by dehydrogenation, and hydrolysis were the major Phase I metabolic pathways of mitapivat. The chief Phase II metabolism pathway was glucuronide conjugation of oxidised and amide hydrolysed metabolites of mitapivat.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyridinesAnimalsRatsMaleRats, Sprague-DawleyMass SpectrometryPyruvate KinaseOxidation-Reduction

Substanzen

Pyruvate KinasePyridines

Autor:innen und Institutionen

  • Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, India.

ORCID-Profile: Swapnil Jayant Dengale

Förderung

  • Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India

Zitieren

APA

Bodake, S. P., Mukesh, A., Bandgar, A., Shajkumar, K., Wankhade, S., Shaji, A. K., & Dengale, S. J. (2025). Identification of Mitapivat's In Vivo Metabolites in the Rat Model by Quadrupole‐Time‐of‐Flight (Q‐TOF) Mass Spectrometry. Journal of Mass Spectrometry. https://doi.org/10.1002/jms.5126

Vancouver

Bodake SP, Mukesh A, Bandgar A, Shajkumar K, Wankhade S, Shaji AK, et al. Identification of Mitapivat's In Vivo Metabolites in the Rat Model by Quadrupole‐Time‐of‐Flight (Q‐TOF) Mass Spectrometry. Journal of Mass Spectrometry. 2025. doi:10.1002/jms.5126

BibTeX
@article{Bodake2025,
  author = {Bodake, Saurabh Pandurang and Mukesh, Anjali and Bandgar, Akshay and Shajkumar, Kannan and Wankhade, Shrutika and Shaji, Anandhu Kunnath and Dengale, Swapnil Jayant},
  title = {Identification of Mitapivat's In Vivo Metabolites in the Rat Model by Quadrupole‐Time‐of‐Flight (Q‐TOF) Mass Spectrometry},
  journal = {Journal of Mass Spectrometry},
  year = {2025},
  doi = {10.1002/jms.5126}
}
Kostenlos starten →